OurInsightsTitle

Our extensive experience in health technology
assessment (HTA) through providing strategic
advice and guiding evidence generation to
support submissions to UK HTA bodies, enables
us to provide you with a tailored solution to
reimbursement and patient access.

A systematic approach to understanding challenges in the health technology assessment of rare diseases. Presented at: WODC Europe 2025; 28-29 October 2025; Amsterdam, Netherlands.

Register to access the Tolley insights